Clinical Trials Browser

Phase NA × Recurrence × camrelizumab × Clear all

NCT03914352 2019-04-16

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence